Effect of Liraglutide on Heart Frequency in Healthy Volunteers
Status:
Completed
Trial end date:
2006-11-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in the United States of America (USA). The aim of this trial is to
investigate if liraglutide effects the QTc interval. Moxifloxacin (Avelox®) is administered
as positive control.
Phase:
Phase 1
Details
Lead Sponsor:
Novo Nordisk A/S
Treatments:
Fluoroquinolones Liraglutide Moxifloxacin Norgestimate, ethinyl estradiol drug combination